Roche launches COVID-19 variant test to help monitor mutations
ZURICH (Reuters) – Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on Tuesday. The test here runs on widely used high-throughput systems and is for research purposes only.
“Periodic assessments against emerging variants have shown that Roche’s current diagnostic tests for detecting active SARS-CoV-2 infections remain accurate and effective,” it said.
![](https://www.healthbroadcastingservice.com/wp-content/uploads/2022/05/HBS_The_Rebranded-e1518614882351.png)